Genocea Biosciences Inc
OTC:GNCAQ
Genocea Biosciences Inc
OTC:GNCAQ
Price:
0.0001
USD
Market Cap:
$5.9k
Cash Flow Statement
Cash Flow Statement
Genocea Biosciences Inc
Genocea Biosciences Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(39)
|
(44)
|
(33)
|
|
| Depreciation & Amortization |
1
|
1
|
2
|
|
| Stock-Based Compensation |
2
|
2
|
4
|
|
| Other Non-Cash Items |
1
|
(2)
|
(16)
|
|
| Cash Interest Paid |
1
|
1
|
1
|
|
| Change in Working Capital |
(1)
|
3
|
2
|
|
| Cash from Operating Activities |
(38)
N/A
|
(42)
-10%
|
(45)
-9%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(1)
|
(3)
|
(3)
|
|
| Other Items |
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(3)
-135%
|
(3)
-26%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
55
|
84
|
12
|
|
| Net Issuance of Debt |
(2)
|
(0)
|
(5)
|
|
| Other |
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
53
N/A
|
84
+58%
|
6
-93%
|
|
| Change in Cash | ||||
| Net Change in Cash |
14
N/A
|
40
+182%
|
(43)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(39)
N/A
|
(44)
-14%
|
(49)
-10%
|
|
Switch to:
Switch to:
See Also
Discover More
